Autobio Diagnostics Co., Ltd.

Equities

603658

CNE100002GC4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
53.2 ^CNY	+1.24%		-2.51%	-6.68%

04:47am	Autobio Diagnostics' Q1 Profit Jumps 34%	MT
03:56am	Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat	MT

Autobio Diagnostics Co., Ltd. Announces Earnings Results for the First Three Quarter of 2017

October 25, 2017

Autobio Diagnostics Co., Ltd. announced earnings results for the first three quarter of 2017. For the first three quarters, the company reported basic earnings per share of CNY 0.77 and weighted average return on net assets of 20.13%.

Latest news about Autobio Diagnostics Co., Ltd.

Autobio Diagnostics' Q1 Profit Jumps 34%	10:47pm	MT
Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat	09:56pm	MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.	Apr. 01	CI
Autobio Diagnostics Secures Registration Certificates for 11 Devices	Apr. 01	MT
Autobio Diagnostics Gets Regulatory Nod in China for 16 Devices	Feb. 23	MT
Autobio Diagnostics Co., Ltd. commences an Equity Buyback Plan for CNY 500 million worth of its shares, under the authorization approved on February 20, 2024.	Feb. 20	CI
Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan.	Jan. 28	CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to S&P Global BMI Index	23-09-18	CI
Autobio Diagnostics Logs Low Single-Digit Earnings Growth in H1	23-08-18	MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Autobio Diagnostics Gets Registration Certificates for Five Devices	23-05-24	MT
Shenzhen Meili Namikong Technology Co., Ltd. announced that it has received funding from Autobio Diagnostics Co., Ltd.	23-04-25	CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to FTSE All-World Index	23-03-20	CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.	23-03-17	CI
Autobio Diagnostics Co., Ltd.'s Equity Buyback announced on March 19, 2022, has closed with 5,260,910 shares, representing 0.90% for CNY 243.27 million.	23-03-16	CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.	23-01-03	CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.	22-10-10	CI
Autobio Diagnostics Secure Nine Registration Certificates in China	22-09-27	MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-10	CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.	22-07-01	CI

Chart Autobio Diagnostics Co., Ltd.

Duration

Period

More charts

Company Profile

Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-18 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Autobio Diagnostics Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

53.2 CNY

Average target price

61.48 CNY

Spread / Average Target

+15.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
AUTOBIO DIAGNOSTICS CO., LTD.	-6.68%	4.27B
BIOMÉRIEUX	-1.59%	12.47B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-17.62%	6.99B
DIASORIN S.P.A.	-3.93%	5.1B
LANTHEUS HOLDINGS, INC.	+0.53%	4.27B
10X GENOMICS, INC.	-48.27%	3.45B
ANDON HEALTH CO., LTD.	+7.09%	2.61B
VITROLIFE AB	-13.71%	2.08B
MYRIAD GENETICS, INC.	-3.40%	1.67B
SHANGHAI RUNDA MEDICAL TECHNOLOGY CO., LTD.	-12.04%	1.48B

Diagnostic & Testing Substances